ahlam1399
02-25-2016, 03:22 PM
UPDATE 1-AstraZeneca?s $4 bln Acerta deal endorsed by orphan drug status
LONDON, Feb 25 (Reuters) - AstraZeneca's bold moveto buy 55 percent of privately held biotech firm Acerta Pharmafor $4 billion in December has been vindicated, at least inpart, by the award of...http://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=vPqqcKw_REY:kkdq26aoy_8:yI l2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?i=vPqqcKw_REY:kkdq26aoy_8:V_ sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=vPqqcKw_REY:kkdq26aoy_8:V_ sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?i=vPqqcKw_REY:kkdq26aoy_8:F7 zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=vPqqcKw_REY:kkdq26aoy_8:F7 zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/governmentfilingsNews/~4/vPqqcKw_REY
LONDON, Feb 25 (Reuters) - AstraZeneca's bold moveto buy 55 percent of privately held biotech firm Acerta Pharmafor $4 billion in December has been vindicated, at least inpart, by the award of...http://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=vPqqcKw_REY:kkdq26aoy_8:yI l2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?i=vPqqcKw_REY:kkdq26aoy_8:V_ sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=vPqqcKw_REY:kkdq26aoy_8:V_ sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?i=vPqqcKw_REY:kkdq26aoy_8:F7 zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=vPqqcKw_REY:kkdq26aoy_8:F7 zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/governmentfilingsNews/~4/vPqqcKw_REY